Possibly — but there are few reports. 90% of 10 people who reported on Semaglutide for blood sugar say it improved. 0% noticed no change and 10% say it got worse.
“Started working right away. First day I didn't eat for 8 hours and I only did because I knew I needed to.”
Conclusion: This study shows that new anti-diabetic drugs, particularly GLP1-RA and Tirzepatide, are the most effective in inducing weight loss in patients with type 2 diabetes. Interestingly, exenatide appears to be the only GLP1-RA that induces a mild weight loss.
Conclusion: Among individuals with obesity without type 2 diabetes, subcutaneous semaglutide is effective for weight loss with an 11.85% reduction from baseline compared to placebo. This supports the use of semaglutide for weight management in obesity. However, risk of gastrointestinal adverse events, discontinuation of treatment and serious adverse events were higher in the semaglutide group versus placebo.
Based on few reports — treat as anecdotal. Information only — not medical advice. How we count